ICUI - ICU Medical Inc | BullzEye View

ICUI

$163.91 +0.00 (+0.00%)

Pre-Market: $163.91 +0.00 (+0.00%)

Last updated: Oct 13, 2026 10:08

52-Week Range

$163.91

$113.37 $163.91 $192.85

Fundamentals Overview

ICU Medical Inc is in the middle of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 135.6 P/B 1.7 P/S 1.89

Profitability

ROE 1.41% Net margin 1.4%

Risk (Beta)

0.89 — in line vol

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 44% confidence Risk: Moderate Volatility — Beta 0.89. Diversify and only invest what you can afford to lose.

Pressures (Sell):

P/E 135.6 (premium)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$4.10B

P/E (TTM)

135.64

EPS (TTM)

N/A

Dividend Yield

N/A

52-Week Range

$113.37 - $192.85

Volume vs Avg

N/A

Beta

0.89

About

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital car...

Sector: Healthcare

Headquarters: US

Website: www.icumed.com

Beta: 0.89 (Less volatile than market)

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric	Value
Valuation
P/E (TTM)	135.64
PEG (TTM)	N/A
P/B (TTM)	1.7
P/S (TTM)	1.89
Profitability
ROE (TTM)	1.41%
ROA (TTM)	75%
Revenue growth (YoY)	N/A
Net margin (TTM)	1.39%
Gross margin (TTM)	39.13%
Operating margin (TTM)	3.47%
Debt to equity (TTM)	0.58

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for ICUI.

Loading analyst coverage...

Price target data is not available for this symbol from the current data source.

Stock Grades (Institutions)

No stock grades available for this symbol.

No price targets, ratings snapshot, or grades available for this symbol.